William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
Krystal Biotech Announces Proposed $200 Million Public Offering of Common Stock
-
Krystal Biotech to Present at the William Blair BioTech Conference
-
UPDATE: Krystal Biotech (KRYS) Prices 2.275M Share Common Offering at $55/Sh
-
Krystal Biotech Announces Pricing of $125 Million Public Offering of Common Stock
-
William Blair Sees Biotech M&A Continuing in 2020; Issues Top 10 Predictions
-
Krystal Biotech (KRYS) Prices 2.5M Share Common Offering at $40/Sh
-
Krystal Biotech Announces Pricing of $100.0 Million Public Offering of Common Stock
-
Krystal Biotech Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
Krystal Biotech (KRYS) Prices 3M Share Offering at $20/Sh
-
Krystal Biotech Announces Pricing of $60.0 Million Public Offering of Common Stock
-
Krystal Biotech (KRYS) Commences $60M Public Offering of Common Stoc
-
Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common Stock
-
William Blair Positive On Krystal Biotech (KRYS) After NDR, Key Catalyst Coming In 4Q

